These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8837592)

  • 21. Activated CD4+CCR5+ T cells in the rectum predict increased SIV acquisition in SIVGag/Tat-vaccinated rhesus macaques.
    Carnathan DG; Wetzel KS; Yu J; Lee ST; Johnson BA; Paiardini M; Yan J; Morrow MP; Sardesai NY; Weiner DB; Ertl HC; Silvestri G
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):518-23. PubMed ID: 25550504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses.
    Hel Z; Nacsa J; Tryniszewska E; Tsai WP; Parks RW; Montefiori DC; Felber BK; Tartaglia J; Pavlakis GN; Franchini G
    J Immunol; 2002 Nov; 169(9):4778-87. PubMed ID: 12391187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What's the matter with HIV-directed killer T cells?
    Wick D; Self SG
    J Theor Biol; 2002 Nov; 219(1):19-31. PubMed ID: 12392972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus (SIV) vaccine enhances protection against neutralization-resistant mucosal SIV infection.
    Kwa S; Sadagopal S; Shen X; Hong JJ; Gangadhara S; Basu R; Victor B; Iyer SS; LaBranche CC; Montefiori DC; Tomaras GD; Villinger F; Moss B; Kozlowski PA; Amara RR
    J Virol; 2015 Apr; 89(8):4690-5. PubMed ID: 25653428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
    Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G
    J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination with Live Attenuated Simian Immunodeficiency Virus (SIV) Protects from Mucosal, but Not Necessarily Intravenous, Challenge with a Minimally Heterologous SIV.
    Sutton MS; Burns CM; Weiler AM; Balgeman AJ; Braasch A; Lehrer-Brey G; Friedrich TC; O'Connor SL
    J Virol; 2016 Jun; 90(12):5541-5548. PubMed ID: 26962218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.
    Egan MA; Charini WA; Kuroda MJ; Schmitz JE; Racz P; Tenner-Racz K; Manson K; Wyand M; Lifton MA; Nickerson CE; Fu T; Shiver JW; Letvin NL
    J Virol; 2000 Aug; 74(16):7485-95. PubMed ID: 10906202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination of pregnant macaques protects newborns against mucosal simian immunodeficiency virus infection.
    Van Rompay KK; Otsyula MG; Tarara RP; Canfield DR; Berardi CJ; McChesney MB; Marthas ML
    J Infect Dis; 1996 Jun; 173(6):1327-35. PubMed ID: 8648204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective mucosal immunity elicited by targeted lymph node immunization with a subunit SIV envelope and core vaccine in macaques.
    Lehner T; Wang Y; Cranage M; Bergmeier LA; Mitchell E; Tao L; Hall G; Dennis M; Cook N; Jones I; Doyle C
    Dev Biol Stand; 1998; 92():225-35. PubMed ID: 9554279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of antigen-specific killer T lymphocyte responses using subunit SIVmac251 gag and env vaccines containing QS-21 saponin adjuvant.
    Newman MJ; Munroe KJ; Anderson CA; Murphy CI; Panicali DL; Seals JR; Wu JY; Wyand MS; Kensil CR
    AIDS Res Hum Retroviruses; 1994 Jul; 10(7):853-61. PubMed ID: 7986590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody-secreting cells specific for simian immunodeficiency virus antigens in lymphoid and mucosal tissues of immunized macaques.
    Bergmeier LA; Mitchell EA; Hall G; Cranage MP; Cook N; Dennis M; Lehner T
    AIDS; 1998 Jul; 12(10):1139-47. PubMed ID: 9677162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus.
    Dale CJ; De Rose R; Stratov I; Chea S; Montefiori DC; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Law M; Kent SJ
    J Virol; 2004 Dec; 78(24):13819-28. PubMed ID: 15564490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early events in sexual transmission of HIV and SIV and opportunities for interventions.
    Haase AT
    Annu Rev Med; 2011; 62():127-39. PubMed ID: 21054171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates.
    Bertley FM; Kozlowski PA; Wang SW; Chappelle J; Patel J; Sonuyi O; Mazzara G; Montefiori D; Carville A; Mansfield KG; Aldovini A
    J Immunol; 2004 Mar; 172(6):3745-57. PubMed ID: 15004179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.
    Shiver JW; Fu TM; Chen L; Casimiro DR; Davies ME; Evans RK; Zhang ZQ; Simon AJ; Trigona WL; Dubey SA; Huang L; Harris VA; Long RS; Liang X; Handt L; Schleif WA; Zhu L; Freed DC; Persaud NV; Guan L; Punt KS; Tang A; Chen M; Wilson KA; Collins KB; Heidecker GJ; Fernandez VR; Perry HC; Joyce JG; Grimm KM; Cook JC; Keller PM; Kresock DS; Mach H; Troutman RD; Isopi LA; Williams DM; Xu Z; Bohannon KE; Volkin DB; Montefiori DC; Miura A; Krivulka GR; Lifton MA; Kuroda MJ; Schmitz JE; Letvin NL; Caulfield MJ; Bett AJ; Youil R; Kaslow DC; Emini EA
    Nature; 2002 Jan; 415(6869):331-5. PubMed ID: 11797011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increases in NKG2C Expression on T Cells and Higher Levels of Circulating CD8
    Hodara VL; Parodi LM; Keckler MS; Giavedoni LD
    AIDS Res Hum Retroviruses; 2016; 32(10-11):1125-1134. PubMed ID: 26986800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paradigm change in immune correlation: cellular or humoral?
    Matsuo K; Yamamoto N
    Expert Rev Vaccines; 2010 Sep; 9(9):985-7. PubMed ID: 20822339
    [No Abstract]   [Full Text] [Related]  

  • 38. Intravenous inoculation of replication-deficient recombinant vaccinia virus DIs expressing simian immunodeficiency virus gag controls highly pathogenic simian-human immunodeficiency virus in monkeys.
    Izumi Y; Ami Y; Matsuo K; Someya K; Sata T; Yamamoto N; Honda M
    J Virol; 2003 Dec; 77(24):13248-56. PubMed ID: 14645581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of simian immunodeficiency virus (SIV)-specific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen.
    Hel Z; Tsai WP; Thornton A; Nacsa J; Giuliani L; Tryniszewska E; Poudyal M; Venzon D; Wang X; Altman J; Watkins DI; Lu W; von Gegerfelt A; Felber BK; Tartaglia J; Pavlakis GN; Franchini G
    J Immunol; 2001 Dec; 167(12):7180-91. PubMed ID: 11739541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relevance of studying T cell responses in SIV-infected rhesus macaques.
    Valentine LE; Watkins DI
    Trends Microbiol; 2008 Dec; 16(12):605-11. PubMed ID: 18964016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.